Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Nevirapine for prophylaxis of HIV infection

June 11, 1997

Introduction of Rescriptor in late June

June 10, 1997

Anti-HIV vaccines reported by Duke University

June 6, 1997

Agents for HIV, tumors and autoimmune diseases from Boehringer Mannheim

June 6, 1997

Multikine progresses in clinical trials

June 6, 1997

Bristol-Myers Squibb expands protease inhibitor research

June 5, 1997

In vitro anti-HIV activity of FddA

June 5, 1997

Update on HIV research at Sheffield

June 4, 1997

Procept completes phase I trial of PRO-2000 gel

June 3, 1997

Vion antiinfective covered under U.S. patent

June 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...